跳至主要内容
临床试验/ISRCTN22471573
ISRCTN22471573已完成未知

Combined Immunosuppression and Radiotherapy in Thyroid Eye Disease

niversity of Bristol (UK)0 个研究点目标入组 100 人开始时间: 2006年2月1日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Mourits' Clinical Activity Score more than or equal to four (worst eye) or more than two (worst eye) with a history of proptosis (defined as either subjective unilateral proptosis confirmed by asymmetry in exophthalmometry of more than 2 mm or subjective bilateral proptosis) or motility restriction (defined as intermittent, inconstant or constant diplopia grade) which is less than six months long
  • 2. Past or present history of abnormal Thyroid Gland Function (TGF) or a clinical diagnosis of TED made and confirmed by more than two muscle involvement on Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan plus a history of recent onset motility restriction and/or proptosis

排除标准

  • 1. Age less than 20 or greater than 75 years
  • 2. Optic neuropathy
  • 3. Mourits? Clinical Activity Score more than four without proptosis or motility restriction
  • 4. Pre-existing glaucoma with a characteristic optic disc appearance and associated visual field defect
  • 5. Use of radioiodine within the last three months
  • 6. Pre-existing diabetes mellitus (not simply steroid-induced disease from recent therapy)
  • 7. Previous adverse event associated with, or contraindication to, either prednisolone or azathioprine
  • 8. Within six months of pregnancy, women planning pregnancy
  • 9. Lactation
  • 10. Haemoglobin concentration, total white cell count or platelet count below the local laboratory's reference range
  • 11. Low, intermediate or high Thiopurine Methyltransferase (TPMT) activity
  • 12. Lymphocyte count less than 0.8 x 10^9/l
  • 13. Abnormal renal function (assessed by urea and creatinine levels above the local laboratory?s reference range)
  • 14. Abnormal liver function, specifically: bilirubin, alanine aminotransferase or alkaline phosphatase concentrations above the local laboratory?s reference range
  • 15. Malignant or pre-malignant (dysplastic) condition within the past five years
  • 16. Previous tuberculosis
  • 17. Shingles within the past three months
  • 18. Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS)
  • 19. Concurrent use of:
  • a. Other immunosuppressive or cytotoxic agents
  • b. Allopurinol
  • 20. Live vaccines within the past three months
  • 21. Previous orbital irradiation

研究者

发起方
niversity of Bristol (UK)

相似试验

Combined Immunosuppression and Radiotherapy in... | 临床试验